Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 of Children at the Age of 12-17 Years Inclusive"

Conditions

• Vaccine

Interventions

• BIOLOGICAL: Vaccine for intramuscular injection
• OTHER: Placebo comparator (without active ingredient) for intramuscular injection

Sponsor

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products